Guidelines on Developmental Toxicity Tests: Brief Insights.

Area of Science:

• Developmental toxicology
• Reproductive toxicology
• Regulatory science

Background:

• Ensuring human health and environmental safety necessitates rigorous testing of new substances for reproductive and developmental toxicity.
• Traditional in vivo mammalian models offer comprehensive assessment but face increasing ethical and regulatory pressure to reduce vertebrate animal use.
• The field is actively seeking and validating alternative testing strategies to meet these evolving demands.

Purpose of the Study:

• To review and describe approved guidelines for standard and alternative methods in reproductive and developmental toxicity testing.
• To discuss the challenges and progress in developing and validating alternative assays for reproductive toxicity endpoints.
• To assess the current regulatory and scientific status of these testing strategies.

Main Methods:

• Review of existing literature and regulatory guidelines for developmental and reproductive toxicity testing.
• Enumeration and brief description of both standard in vivo and emerging alternative in vitro and non-mammalian test models.
• Analysis of the scientific and regulatory standing of various testing approaches.

Main Results:

• Reproductive toxicity assessment is complex and challenging to replace entirely with alternative methods due to the intricate mechanisms involved in fertility and development.
• Alternative models, including in vitro systems and non-mammalian species, are advancing but face hurdles in validation and predictability.
• Current alternative strategies are expected to reduce, but not completely replace, in vivo animal testing for reproductive toxicity in the near future.

Conclusions:

• The development and validation of alternative testing methods are crucial for reducing animal use in developmental toxicology.
• While significant progress has been made, in vivo studies remain essential for comprehensive reproductive toxicity assessment.
• Continued research and validation efforts are needed to enhance the reliability and regulatory acceptance of alternative assays.